Repligen | RGEN - Trade Creditors


Repligen reported $34.66M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Agilent USD 615M 13M Mar/2026
Align Technology USD 123.72M 2.27M Mar/2026
Bio Techne USD 95.6M 3.97M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Bruker USD 269.1M 53.2M Mar/2026
Charles River Laboratories USD 133.95M 14.85M Mar/2026
Danaher USD 1.79B 54M Mar/2026
Dentsply International USD 259M 41M Mar/2026
General Electric Aerospace USD 10.68B 605M Mar/2026
Henry Schein USD 1.04B 111M Mar/2026
Illumina USD 218M 22M Mar/2026
IQVIA Holdings USD 3.64B 112M Mar/2026
Mettler Toledo International USD 228.72M 37.91M Mar/2026
Myriad Genetics USD 32.6M 2.6M Mar/2026
OraSure Technologies USD 10.63M 4.11M Mar/2026
Pacific Biosciences Of California USD 13.61M 7.16M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Repligen USD 34.66M 4.65M Mar/2026
Revvity USD 169.68M 15.78M Mar/2026
Standard Biotools USD 8.01M 2.6M Mar/2026
Thermo Fisher Scientific USD 3.34B 278M Mar/2026
Waters USD 103.78M 11.95M Dec/2025
West Pharmaceutical Services USD 252.3M 1.4M Mar/2026